Elligo Health Research
Chris Pepper is a seasoned professional in medical technology and clinical development with extensive experience in strategic leadership and business development roles across multiple organizations. Currently serving as the Sr. Director of Medtech & IVD Strategy at Elligo Health Research since June 2024, previous positions include Clinical Business Development Executive at NAMSA and Director of Life Science Strategy & Research at Arterys, where Chris focused on developing the Arterys Labs business unit and positioning AI algorithms for clinical trial applications. Chris has a solid background in defining digital health strategies and managing global sales strategies for various sectors, including cardiovascular and neurology. An alum of the University of Mississippi, Chris holds a Bachelor of Business Administration in Marketing and Advertising.
This person is not in any offices
Elligo Health Research
Elligo offers direct access to 150 million known patients with their physicians and research practice management solutions to accelerate clinical research.